Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply

Lancet Oncol. 2017 Dec;18(12):e709-e710. doi: 10.1016/S1470-2045(17)30856-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials, Phase III as Topic*
  • Decision Making*